Logo image of BC

BRUNSWICK CORP (BC) Stock Fundamental Analysis

USA - NYSE:BC - US1170431092 - Common Stock

66.34 USD
+1.24 (+1.9%)
Last: 10/3/2025, 8:24:37 PM
66.34 USD
0 (0%)
After Hours: 10/3/2025, 8:24:37 PM
Fundamental Rating

5

BC gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 33 industry peers in the Leisure Products industry. BC has a medium profitability rating, but doesn't score so well on its financial health evaluation. BC has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year BC was profitable.
BC had a positive operating cash flow in the past year.
BC had positive earnings in each of the past 5 years.
Each year in the past 5 years BC had a positive operating cash flow.
BC Yearly Net Income VS EBIT VS OCF VS FCFBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

The Return On Assets of BC (0.72%) is better than 60.61% of its industry peers.
BC has a Return On Equity of 2.18%. This is in the better half of the industry: BC outperforms 66.67% of its industry peers.
BC has a Return On Invested Capital of 4.97%. This is in the better half of the industry: BC outperforms 69.70% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BC is above the industry average of 7.78%.
The 3 year average ROIC (11.29%) for BC is well above the current ROIC(4.97%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.72%
ROE 2.18%
ROIC 4.97%
ROA(3y)6.58%
ROA(5y)8.11%
ROE(3y)20.05%
ROE(5y)23.17%
ROIC(3y)11.29%
ROIC(5y)12.56%
BC Yearly ROA, ROE, ROICBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

The Profit Margin of BC (0.82%) is better than 63.64% of its industry peers.
BC's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 6.12%, BC is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
BC's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 24.72%, BC is doing worse than 60.61% of the companies in the same industry.
In the last couple of years the Gross Margin of BC has remained more or less at the same level.
Industry RankSector Rank
OM 6.12%
PM (TTM) 0.82%
GM 24.72%
OM growth 3Y-15.92%
OM growth 5Y-7.05%
PM growth 3Y-37.44%
PM growth 5YN/A
GM growth 3Y-2.7%
GM growth 5Y-0.86%
BC Yearly Profit, Operating, Gross MarginsBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BC is creating some value.
Compared to 1 year ago, BC has less shares outstanding
BC has less shares outstanding than it did 5 years ago.
The debt/assets ratio for BC is higher compared to a year ago.
BC Yearly Shares OutstandingBC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
BC Yearly Total Debt VS Total AssetsBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

BC has a debt to FCF ratio of 4.43. This is a neutral value as BC would need 4.43 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.43, BC is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
BC has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
BC has a Debt to Equity ratio of 1.10. This is in the lower half of the industry: BC underperforms 69.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 4.43
Altman-Z N/A
ROIC/WACC0.5
WACC10.04%
BC Yearly LT Debt VS Equity VS FCFBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

BC has a Current Ratio of 1.68. This is a normal value and indicates that BC is financially healthy and should not expect problems in meeting its short term obligations.
BC has a Current ratio of 1.68. This is in the lower half of the industry: BC underperforms 63.64% of its industry peers.
BC has a Quick Ratio of 1.68. This is a bad value and indicates that BC is not financially healthy enough and could expect problems in meeting its short term obligations.
BC has a worse Quick ratio (0.70) than 75.76% of its industry peers.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 0.7
BC Yearly Current Assets VS Current LiabilitesBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

4

3. Growth

3.1 Past

BC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -55.41%.
The Earnings Per Share has been growing slightly by 1.13% on average over the past years.
Looking at the last year, BC shows a very negative growth in Revenue. The Revenue has decreased by -11.58% in the last year.
BC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.97% yearly.
EPS 1Y (TTM)-55.41%
EPS 3Y-18%
EPS 5Y1.13%
EPS Q2Q%-35.56%
Revenue 1Y (TTM)-11.58%
Revenue growth 3Y-3.6%
Revenue growth 5Y4.97%
Sales Q2Q%0.21%

3.2 Future

BC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.12% yearly.
The Revenue is expected to grow by 3.75% on average over the next years.
EPS Next Y-27.16%
EPS Next 2Y-2.67%
EPS Next 3Y8.05%
EPS Next 5Y20.12%
Revenue Next Year0.43%
Revenue Next 2Y2.49%
Revenue Next 3Y3.52%
Revenue Next 5Y3.75%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BC Yearly Revenue VS EstimatesBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
BC Yearly EPS VS EstimatesBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15

6

4. Valuation

4.1 Price/Earnings Ratio

BC is valuated rather expensively with a Price/Earnings ratio of 21.19.
Based on the Price/Earnings ratio, BC is valued cheaply inside the industry as 81.82% of the companies are valued more expensively.
BC's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.86.
The Price/Forward Earnings ratio is 15.36, which indicates a correct valuation of BC.
84.85% of the companies in the same industry are more expensive than BC, based on the Price/Forward Earnings ratio.
BC is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.32, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 21.19
Fwd PE 15.36
BC Price Earnings VS Forward Price EarningsBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

72.73% of the companies in the same industry are more expensive than BC, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, BC is valued cheaply inside the industry as 93.94% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.44
EV/EBITDA 10.28
BC Per share dataBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

BC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)18.69
EPS Next 2Y-2.67%
EPS Next 3Y8.05%

6

5. Dividend

5.1 Amount

BC has a Yearly Dividend Yield of 2.64%.
Compared to an average industry Dividend Yield of 4.26, BC pays a better dividend. On top of this BC pays more dividend than 96.97% of the companies listed in the same industry.
BC's Dividend Yield is comparable with the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 2.64%

5.2 History

The dividend of BC is nicely growing with an annual growth rate of 13.66%!
BC has been paying a dividend for at least 10 years, so it has a reliable track record.
BC has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)13.66%
Div Incr Years12
Div Non Decr Years16
BC Yearly Dividends per shareBC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

269.47% of the earnings are spent on dividend by BC. This is not a sustainable payout ratio.
The dividend of BC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP269.47%
EPS Next 2Y-2.67%
EPS Next 3Y8.05%
BC Yearly Income VS Free CF VS DividendBC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M
BC Dividend Payout.BC Dividend Payout, showing the Payout Ratio.BC Dividend Payout.PayoutRetained Earnings

BRUNSWICK CORP

NYSE:BC (10/3/2025, 8:24:37 PM)

After market: 66.34 0 (0%)

66.34

+1.24 (+1.9%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)07-24 2025-07-24/bmo
Earnings (Next)10-23 2025-10-23/bmo
Inst Owners108.48%
Inst Owner Change1.66%
Ins Owners0.92%
Ins Owner Change0.56%
Market Cap4.33B
Analysts75.38
Price Target68.87 (3.81%)
Short Float %9.15%
Short Ratio6.78
Dividend
Industry RankSector Rank
Dividend Yield 2.64%
Yearly Dividend1.67
Dividend Growth(5Y)13.66%
DP269.47%
Div Incr Years12
Div Non Decr Years16
Ex-Date08-20 2025-08-20 (0.43)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)77.94%
Min EPS beat(2)18.98%
Max EPS beat(2)136.9%
EPS beat(4)3
Avg EPS beat(4)40.08%
Min EPS beat(4)-5.65%
Max EPS beat(4)136.9%
EPS beat(8)3
Avg EPS beat(8)16.76%
EPS beat(12)4
Avg EPS beat(12)10.57%
EPS beat(16)8
Avg EPS beat(16)8.78%
Revenue beat(2)2
Avg Revenue beat(2)8.87%
Min Revenue beat(2)4.88%
Max Revenue beat(2)12.87%
Revenue beat(4)3
Avg Revenue beat(4)5.03%
Min Revenue beat(4)-4.26%
Max Revenue beat(4)12.87%
Revenue beat(8)3
Avg Revenue beat(8)-0.91%
Revenue beat(12)3
Avg Revenue beat(12)-2.47%
Revenue beat(16)5
Avg Revenue beat(16)-2.05%
PT rev (1m)6.78%
PT rev (3m)13.38%
EPS NQ rev (1m)-0.62%
EPS NQ rev (3m)-24.4%
EPS NY rev (1m)0.33%
EPS NY rev (3m)1.46%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)-7.21%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)1.94%
Valuation
Industry RankSector Rank
PE 21.19
Fwd PE 15.36
P/S 0.85
P/FCF 8.44
P/OCF 6.54
P/B 2.28
P/tB 222.26
EV/EBITDA 10.28
EPS(TTM)3.13
EY4.72%
EPS(NY)4.32
Fwd EY6.51%
FCF(TTM)7.86
FCFY11.85%
OCF(TTM)10.14
OCFY15.29%
SpS78.02
BVpS29.16
TBVpS0.3
PEG (NY)N/A
PEG (5Y)18.69
Profitability
Industry RankSector Rank
ROA 0.72%
ROE 2.18%
ROCE 6.99%
ROIC 4.97%
ROICexc 5.35%
ROICexgc 9.82%
OM 6.12%
PM (TTM) 0.82%
GM 24.72%
FCFM 10.08%
ROA(3y)6.58%
ROA(5y)8.11%
ROE(3y)20.05%
ROE(5y)23.17%
ROIC(3y)11.29%
ROIC(5y)12.56%
ROICexc(3y)12.61%
ROICexc(5y)14.42%
ROICexgc(3y)24.11%
ROICexgc(5y)28.09%
ROCE(3y)15.87%
ROCE(5y)17.66%
ROICexcg growth 3Y-26.29%
ROICexcg growth 5Y-12.51%
ROICexc growth 3Y-22.36%
ROICexc growth 5Y-13.21%
OM growth 3Y-15.92%
OM growth 5Y-7.05%
PM growth 3Y-37.44%
PM growth 5YN/A
GM growth 3Y-2.7%
GM growth 5Y-0.86%
F-Score5
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 4.43
Debt/EBITDA 3.47
Cap/Depr 50.96%
Cap/Sales 2.92%
Interest Coverage 250
Cash Conversion 109.72%
Profit Quality 1234.86%
Current Ratio 1.68
Quick Ratio 0.7
Altman-Z N/A
F-Score5
WACC10.04%
ROIC/WACC0.5
Cap/Depr(3y)110.64%
Cap/Depr(5y)120.16%
Cap/Sales(3y)4.47%
Cap/Sales(5y)4.44%
Profit Quality(3y)112.61%
Profit Quality(5y)110.96%
High Growth Momentum
Growth
EPS 1Y (TTM)-55.41%
EPS 3Y-18%
EPS 5Y1.13%
EPS Q2Q%-35.56%
EPS Next Y-27.16%
EPS Next 2Y-2.67%
EPS Next 3Y8.05%
EPS Next 5Y20.12%
Revenue 1Y (TTM)-11.58%
Revenue growth 3Y-3.6%
Revenue growth 5Y4.97%
Sales Q2Q%0.21%
Revenue Next Year0.43%
Revenue Next 2Y2.49%
Revenue Next 3Y3.52%
Revenue Next 5Y3.75%
EBIT growth 1Y-50.21%
EBIT growth 3Y-18.95%
EBIT growth 5Y-2.43%
EBIT Next Year27.55%
EBIT Next 3Y18.74%
EBIT Next 5Y18.04%
FCF growth 1Y57.53%
FCF growth 3Y-4.9%
FCF growth 5Y5.54%
OCF growth 1Y-4.15%
OCF growth 3Y-9.08%
OCF growth 5Y-0.13%